Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
BMC Genomics|November 5, 2015
Genomic population structure and prevalence of copy number variations in South African Nguni cattleMagretha Diane Wang, Kennedy Dzama, Charles A Hefer, et al.
Journal of Clinical Pharmacology|April 30, 2026
Limitations of Subgroup Safety Analyses for Drug-Drug Interaction Evaluation: Insights from the Talazoparib P-gp Inhibitor CaseDiane Wang, Charvi Nanavati, Derek Z Yang, et al.
British Journal of Clinical Pharmacology|March 2, 2022
Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairmentCen Guo, Yanke Yu, Jayeta Chakrabarti, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthBrion W Murray, Chuangxing Guo, Joseph Piraino, et al.
Clinical Imaging|June 29, 2021
Anti-NMDA receptor encephalitis and brain atrophy in children and adults: A quantitative studyFrederick C Bassal, Matthew Harwood, Ann Oh, et al.
Journal of Cellular and Molecular Medicine|February 25, 2010
Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?Xiangdong Wang, Ka Li, Hong Chen, et al.
Respiratory Physiology & Neurobiology|February 16, 2010
Roles of CC chemokine receptors (CCRs) on lipopolysaccharide-induced acute lung injuryDong Yang, Lin Tong, Diane Wang, et al.
Journal of Clinical Pharmacology|December 17, 2025
Elranatamab Exposure-Safety Analysis in Relapsed or Refractory Multiple MyelomaPooneh Soltantabar, Jennifer Hibma, Diane Wang, et al.
Pageof 15